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Abstract
This paper proposes a systematic literature review on ethics and CoviD-19, aiming to understand the impact and the percep-
tion of the pandemic during the first wave (January-June 2020) and the consequences one year later.PubMed was systemati-
cally searched up May 2020 to identify studies that took into consideration various ethical issues that have been arising from 
the Covid-19 outbreak. The eligibility of the papers was determined by two authors, who screened the results mediated by a 
third author. In order to facilitate the screening, the titles were divided into five sub-thematic macro-areas, namely allocation, 
policy, specialist, clinical trials, and technology and, when possible, per geographical area. Specifically, a posteriori, we 
decided to focus on the papers referring to policies and technology, as they highlighted ethical issues that are not overused 
and worthy of particular attention.Thus, 38 studies out of 233 met our inclusion criteria and were fully analysed. Accordingly, 
this review touches on themes such as fairness, equity, transparency of information, the duty of care, racial disparities, the 
marginalisation of the poor, and privacy and ethical concerns.Overall, it was found that despite the increased awareness of 
interdisciplinarity and the essential reference to ethics, many scientific articles use it with little competence, considering it 
only a "humanitarian" enrichment. In fact, as we understand, reflecting a year after the outbreak of the pandemic, although 
Covid-19 is leading scientists to increasingly recognise the importance of ethical issues, there is still a lot of confusion that 
could be helped by establishing international guidelines to act as a moral compass in times of crisis.
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1  Background
The spread of COVID-19 begot what the World Health 
Organisation (WHO) defined a “pandemic” [1], an emer-
gency condition that has often been compared to other dra-
matic events in history (e.g., the Spanish flu in 1918). How-
ever, on closer inspection, COVID-19 can be regarded as an 
unprecedented event with its own specificity.
During the first months of the pandemic, the numerous 
emerging issues were deeply interwoven with ethics, as it is 
unanimously recognized by the works of politics, medicine, 
and science. The interdisciplinarity of such works and their 
continuous and necessary reference to ethics reinforce the 
belief that bioethics, i.e., a "bridge" between different fields 
of knowledge, looks more and more "towards the future" [2]. 
In fact, in the first few months, the contributions of National 
Ethics Committees, International Organizations, National 
Bodies and Professional Association to this topic [3] were 
numerous, very rapid, and accompanied a very heated debate 
on ethical implications between the population and experts 
from various backgrounds. Nonetheless, the continuous ref-
erence to the word “ethics” in the first publications after the 
declaration of COVID-19 pandemic [4–7] highlighted the 
need to clarify the most relevant ethical problems related to 
the scientific community. Hence, it was decided to focus on 
and deepen the subjects that aroused the interest of specialists 
the most. Specifically, existing works of reconstruction and/
or comparison among national and international documents 
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on the relationship between ethics and COVID-19 were not 
taken into consideration, to avoid delving into or discoursing 
about already exhaustively discussed topics.
Consequently, a systematic literature review was opted 
for. Such review was conducted by an interdisciplinary 
working group, comprising biomedical engineers and 
bioethicists, following a multidisciplinary approach, which 
overcomes the outdated Cartesian model of the separation 
of knowledge into “silos” of disciplines [8, 9]. To facilitate 
the screening process, the papers were grouped by macro 
areas that were pinpointed through a thematic analysis [10], 
as explained in the methods. In particular, it was decided 
to analyse only the themes related to policy, technology, 
resource allocation, and low- and middle-income countries 
(LMICs) as they fall within our competences and seem to 
underline relevant ethical questions, which are not always 
adequately or exhaustively discussed. However, the theme 
of resource allocation was excluded a priori, because it is a 
trite topic, currently “abused”, on which anyone expresses 
their opinion independently from their level of expertise 
and knowledge. Moreover, many papers, which had a refer-
ence to ethics in the title, but that, in fact, did not deal with 
analysing the ethical implications of the investigated issues, 
were excluded. In fact, the ultimate purpose of this work 
was to understand the role that scientists recognize in ethics 
and the problems related to it: is it seen as a “humanitarian” 
addition to technical issues or as a structural element and 
perspective from which to analyse specialistic issues?
Therefore, this paper reports a collection of the most 
relevant and less conventional ethics challenges related to 
COVID-19 published in peer-reviewed journals indexed in 
PubMed, analysed through our multidisciplinary lens. These 
ethical issues, which emerged during the first wave of the 
pandemic, were then rediscussed a year later, in order to 
assess whether the first bioethical perspectives related to 
COVID-19 were biased by the close succession of the events 
being analysed, or they were detached enough, and the raised 
issues remain current a year on.
2  Methods
2.1  Systematic literature review
Given the large number of papers and documents that have 
been and are currently being published since the start of the 
pandemic, we decided to conduct a systematic literature review. 
PubMed was selected as the only database to identify all the 
contributions published from 01/01/2020 up to 19/05/2020 
responding to the topics of COVID-19 and ethics. The search 
string was constructed with the following terms combined 
with the Boolean operators AND/OR: “ethics”, “ethical”, 
“bioethics”, “COVID”, “sars cov 2”, “coronavirus” ((ethics 
OR ethical OR bioethics) AND (COVID OR sars cov 2 OR 
coronavirus)). We judged eligible only the papers with full text 
available and in English. In order to facilitate the clustering and 
further screening of the retrieved articles, they were divided into 
the most recurring themes and per geographical area. To this 
regard, the countries were grouped according to the following 
macro groups, based on the retrieved papers: North America, 
Europe, LMICs (e.g., Tunisia), Asia, and Israel. Particular 
attention was dedicated to the contributions regarding LMICs. 
Finally, only the paper pertaining to our field of expertise, i.e., 
technologies and policy, made it through the final selection. 
During this process, two authors independently screened all the 
titles and abstracts for eligibility. Full texts were considered if the 
selection was unclear. A third author reviewed and checked the 
results of the screening search. Any discrepancy was resolved by 
discussion among all the authors. All the relevant papers were 
analysed, summarised and coded to facilitate the reading.
3  Results
3.1  Systematic literature review
Figure 1 shows the electronic database search and the selec-
tion process. Only 38 papers out of the initial 233 resulted 
eligible to be included in our study, which focuses on tech-
nology and policy. Figure 2 shows the division in macro 
groups and Fig. 3 the division per geographical area, when 
applicable. Online Resource 1 presents all the selected 
papers organised by recurring themes.
The 5 pinpointed macro groups of specific works on ethics 
and COVID-19 were: Policy, Resource allocation, Specialists, 
Clinical trials, and Technology. The theme of policies, i.e., of 
the public responses to the crisis, is the one that piques the 
scientists’ interests the most, according to our review. In this 
regard, as already mentioned, our review is not exhaustive and 
does not aim at including all the political guidelines of the 
various countries, because its hermeneutical horizon [11] is 
the point of view of science. Notwithstanding, it was possible 
to identify a series of specific works on different countries, 
which allowed comparisons between different areas of the 
world: LMICs, Asia, Europe, and North America.
The theme of resource allocation is also extremely 
well-liked. In fact, the first wave of the pandemic caused 
a scarcity of resources, globally, without any distinction: 
from personal protective equipment (PPE) to medical 
devices (MDs) (e.g., ventilators, respirators), beds, drugs 
for COVID-19 patients or patients suffering from other 
pathologies, health personnel, and COVID-19 tests. Most 
specifically, this situation of emergency abruptly showed 
the lack of competent ad-hoc bodies. This begot extremely 
heterogeneous approaches to ethics by different individu-
als, regardless their competence in ethics.
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Among the retrieved publications, there were also 
numerous articles on ethics and COVID-19 written by 
specialists from various medical fields (e.g., geriatrics, 
psychiatry, surgery, oncology, and dentistry). Other pub-
lication focuses on all healthcare workers (HCWs), such 
as nurses and midwives, who experienced profound dif-
ficulties in this particular historical moment, the common 
denominator being allocation problems.
A significant number of works was related to clinical tri-
als, in particular concerning vaccines and drugs, dealing with 
detecting the widespread condition of researchers who had to 
readdress the scopes of their research, always respecting high 
ethical standards and safeguarding the testers.
Finally, the last area is that of technology for COVID-19 
(e.g., eHealth) and all the related ethical issues.
4  Discussions
4.1  The duality of trust: on the trustworthiness 
of governments and public trust
Most of the articles included the topic of infodemic, i.e., 
“an over-abundance of information – some accurate and 
some not – that makes it hard for people to find trustwor-
thy sources and reliable guidance when they need it” [12]. 
Misinformation circulating through global digital social 
networks in the first months of this pandemic was focused 
on trust in governments and policy makers [13–15], ques-
tioning the principles of legitimacy and responsibility 
related to information verification and sharing.
But who was the source of such disinformation?
Larson [15] claimed that it is was the governments who 
repressed information hoping to calm anxious publics, as 
it happened in Iran [15, 16] or in China, where healthcare 
workers, who told the truth about the spread of the virus 
and the scarcity of resources, were looked at as “whistle-
blowers” and forced to withdraw their declarations [17]. 
Moreover, some governments deliberately released sup-
posedly reassuring misinformation, risking undermining 
their own credibility and their abilities to help people 
counter real health threats. According to Limaye et al. 
[13], there is a need for joint action between government 
agencies and social media companies for fact-check and 
even removal of false or outdated information. On the 
other hand, according to Bastani and Bahrami [16], there 
is the need of an active and effective presence of health 
professionals and authorities on social media, due to the 
poor legal supervision of online content.
Low-quality research contributed to this misinforma-
tion, too. In fact, the high demand for information caused 
an acceleration in reporting scientific results, with many 
journals publishing without any peer-review and offering 
open-access to everyone. A proxy for the high number 
of low-quality research on COVID-19 is also the unprec-
edented high number of retracted papers. To this regard, 
we searched for papers on COVID-19 or SARS-Cov-2 and 
the previous epidemics/pandemics (i.e., avian flu, swine 
flu, MERS) both on the Retraction Watch Database and 
OvidSP. As a result, as of May 2021, 124 out of 264,530 
papers on COVID-19 (4.68 retractions per 10,000) were 
retracted, compared to 1.16 per 10,000 papers concerning 
the previous pandemics/epidemics.
Apart from being unethical, reporting poor quality 
outcomes is a kind of research misconduct [18] and 
inaccuracy. This could also have other consequences, for 
example exacerbating stigma and discrimination against 
particular populations [19]. In fact, Chowkwanyun and Reed 
[20], analysing the information circulated in the media in 
Wisconsin and Michigan on the high percentage of black 
people affected by Coronavirus, argued that there is always 
the need for contextualisation unless we want to foster harmful 
myths and misunderstanding, which undermine the goal of 
eliminating health inequities. The fear of stigmatization 
towards specific groups of people is likely to worsen if they 
are individuals. In this case, the ethical dilemma is the balance 
between personal and collective interests.
Fig. 1  The flowchart of the systematic literature review
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In hindsight, the public health measures that have been 
implemented can be of different types. Sulmasy and Veatch 
[21] identifies four of them:
1. Contact tracing through the self-reporting of recent 
close interactions by people known to be infected with 
COVID-19. In this regard, Luo et al. [22] reported the 
example of an online questionnaire that circulated in 
China as an internet approach in COVID-19 participa-
tory surveillance.
2. More "draconian" health measures: new surveillance 
technologies that employ facial recognition, security 
cameras, and phone GPS monitoring could attempt to 
identify everyone who spent at least fifteen minutes 
within six feet of every infected individual. Each con-
tact could be forcibly quarantined. In this regard, [23] 
underlined that apps could also be used as a preventive 
approach. However, as Vokinger et al. [24] affirmed, 
trustworthiness and integrity of contact tracing apps 
should be assessed with a framework. A review of the 
tracing apps for the management of COVID-19 can be 
found in [25], where the authors underlined that among 
the advantages there were the increase of personal free-
dom, of personal feelings of safety, and the improvement 
of the management of the quarantine. However, govern-
ments should implement policies to outline requirements 
for these apps and should safeguard privacy, access, 
transparency, the protection and use of these data [24, 
25]. In particular, Santow [26] underlined the need for 
a legal framework to regulate artificial intelligence and 
data sharing, as they can be the cause of discrimination 
and violation of human rights.
Fig. 2  The distribution of the 
articles in 5 macro-areas
Fig. 3  The distribution of the articles per geographical area
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3. Voluntary contact tracing: it relies on the self-led contact 
tracing. However, it is not perfect because patients might 
not remember all their recent contacts.
4. The public naming of infected individuals: in this regard, 
Sulmasy and Veatch [21] described the case of the 
Prestigious University, in which the communication via 
email about the testing positive of a staff member raised a 
heated debate regarding the request to reveal the identity 
of the subject in order to maximize public health benefit 
and slow the spread of the virus. One of the authors argued 
that this could breach confidentiality and be harmful to the 
patient’s privacy, who is free to decide whether to make 
a voluntary disclosure. However, another author believed 
that the confidentiality breach is morally mandatory to 
decrease the risk of contagion for other members of the 
University, because the duty towards the community 
has priority over the right of confidentiality. This is also 
discussed by Persad and Emanuel [27], who reported the 
proposal of some states (i.e., Chile, Germany and the UK) 
to implement “certifications of immunity” or “immunity 
passports” for those who had COVID-19 or who will have 
received the vaccine in the future. In line with the principle 
of the “least restrictive alternative” to achieve public health 
objectives, the author believe that this tracking measure 
is not unethical and cannot be compared to the yellow 
star that the Nazis forced the Jews to wear, because it is 
not a form of discrimination. However, it needs careful 
implementation and scientific support to be ethical in 
practice.
Another category of individuals who place the interests of 
society before their own is that of frontline healthcare work-
ers (HCWs) who are forced to work in precarious conditions 
at their personal risk [28]. However, for them there is also 
another ethical dilemma: that of protecting, together with 
one’s own health, also one’s family and loved ones, which 
often clashes with the duty to treat patients, sometimes in 
the absence of PPE [29, 30]. According to McConnell [31], 
there are several factors that adjust the burden of protecting 
one’s family. The authors argued that the moral demands of 
"Samaritanism" (i.e., one should go out of one’s way to help 
someone else, if it entails a little cost to oneself) do not imply 
that HCWs take on the risks and burdens associated with 
treating COVID-19 to save several lives. Likewise, Thomas 
et al. [30] denounced the low quantity and quality of PPE 
and the inadequacy of the related guidance issued by Public 
Health England. Moreover, he appealed to the precautionary 
principle and praised the ethical framework of Beauchamp 
and Childress [32] that encourages to counterbalance benefi-
cence with non-maleficence. Always according to Thomas 
JP, political leaders have the moral duty to be open and hon-
est, when informing all frontline HCWs of their own personal 
risks in caring for COVID-19 patients.
Nonetheless, as in all the aspects of life, economical 
evaluations cannot be excluded. Hilsenrath [33] presented 
a very sensitive issue, that of confronting the medical duty 
to save lives and the reasoning of economists, who invite 
people to make decisions on appropriate costs. The author 
lucidly underlined that although the issue is often bypassed 
by political leaders, especially Americans, it should be faced 
by considering an ethical balance, certainly painful, between 
the ethical and economic damage that countries are experi-
encing in this historical moment.
Overall, what is required from governments is trust. 
People place their trust, their lives, health, and economic 
situation in a sensible and transparent decision-making of 
governments. Therefore, as Thomas et al. claimed, "it is a 
reasonable expectation to hold our modern governments 
to the corresponding standards of our modern health pro-
fessionals: specifically, transparency in decision-making 
and the duty of candidate" [30]. Similarly, Lewnard and 
Lo [34] sustained that policymakers maintain the public’s 
trust through the use of evidence-based interventions and 
fully transparent fact-based communication. To give an 
example of this, the author also reported on mathemati-
cal modelling of the viral transmission under different 
scenarios to generate evidence of the efficacy of social 
distancing interventions.
On the other hand, Chaari and Golubnitschaja [35], sup-
porter of 3P (predict, prevent and personalise) medicine, 
proposed “real-time” monitoring based on randomized labo-
ratory tests as a source of evidence. However, this clashed 
with the problem of the lack of tests and the discrepancy 
between officially recorded and real infection cases. In fact, 
this could lead to incorrect political decisions heavily influ-
encing the future of a country (e.g., a long-term economic 
recession due to over-protection of the population, or a post-
containment pandemic rebound due to an under-protection 
of the population). Furthermore, all the measures required 
from governments (i.e., testing, screening, contact tracing, 
social distancing, travel restriction) must be as inclusive as 
possible in particular with vulnerable communities (i.e., 
homeless, those without insurance or employment, disabled, 
immigrant, prisoners) [14, 34]. This also means being aware 
that the use of technology to combat the spread of COVID-
19 could exacerbate racial, socioeconomic and geographic 
disparities for populations that lack access to reliable inter-
net access, devices or technological literacy [36]. Moreover, 
during the pandemic, the benefits of technologies that allow 
relationships beyond social distancing have increasingly 
been experienced and could be a valid assistance tool for 
the elderly [37] and favour the communication of hospital-
ised patients with their families [36]. This response should 
also involve millennials and Generation Z more [38], as, 
despite the negative stereotypes that circulate around them, 
they could offer valuable help to overcome this crisis.
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Certainly, the use of technology, if regulated, can be of 
help to scientists. Indeed, O’Reilly-Shah et al. [39] high-
lighted the shortcomings in the US healthcare IT infrastruc-
tures, underlining the importance of the interoperability of 
healthcare data, which should refrain from the proprietary 
control of vendors and be accessible to healthcare providers, 
especially in times of crisis.
More generally, it could be said that technology and data 
sharing are particularly important for disseminating knowledge 
worldwide. Momtazmanesh et al. [40] sustained that sharing 
and solidarity are at the base of an indispensable international 
collaboration to fight the current and future pandemics. The 
pandemic has increasingly shown the need for an interna-
tional ethical–political coordination framework [23], aiming 
at reducing disparities. In this regard, under the category of 
policy, many contributions regarded LMICs. One of the recur-
rent themes was the stress on already overburdened and under-
funded public healthcare systems in Africa, India, and Latin 
America [41–45]. In a more general comparison between the 
North and the South of the world, Schuklenk et al. [43] affirmed 
that there is a significant difference in the number of available 
intensive care unit beds per population and that the access to 
cures is often wealth-based, as many hospitals in the South are 
private. However, Krishna [42] stated that COVID-19 is just 
another drop in an already full vase, as the Indian healthcare 
system is already plagued by internal issues (e.g., no access to 
medicines, vested political interests etc.). All in all, the policies 
against COVID-19 are, once again, putting the poorest coun-
tries and people at risk [43, 46]. In India, for example, the poor 
were confined in ghettos without a proper social security net 
and their conditions were exacerbated by the lockdown [46]. 
Other approaches used in LMICs to fight COVID-19 include 
the use of fear appeals to regulate people’s behaviours [47]. 
However, it can be argued whether this technique is ethical 
and acceptable or not. On the other hand, Kapata et al. [48] 
positively affirmed that Africa was readier than for the previous 
epidemic outbreaks.
Other diseases, such as vector-borne and non-communi-
cable diseases, and community-acquired infections are often 
included among other stressors [41, 42]. Krishna [42] also 
affirmed that notwithstanding this, COVID-19 obtained much 
more funding compared to other existing deadly diseases (e.g., 
diarrhoea).
Another element contributing to exacerbating the 
situation is the lack of ethics committees in the hospitals to 
regulate and ease the work of healthcare operators. In fact, 
the latter do not only have to face very difficult choices in 
an environment dominated by material scarcity and public 
distrust [41], but they also have to work in precarious 
conditions and their striking for this matter could be seen as 
patient abandonment [43]. With regard to this, Gopichandran 
and Subramaniam [44] recalled the reciprocity principle, 
according to which the state should protect the interests of 
the healthcare workers, who risk their lives to care for those 
who are infected.
Some authors [16, 44, 45, 49] agreed on the need for 
equity and clarity in the way governments inform citizens, 
not to undermine their trust. Most importantly, it was unani-
mously stated that policies for COVID-19 should always be 
adapted to different contexts, above all the ones related to 
minorities, in the respect of traditional beliefs [50], and to 
avoid exacerbations of pre-existing gaps between the rich 
and the poor [46]. To this purpose, self-determination is 
key [51]: in fact, LMICs should independently shape their 
response, relying on international partners in a critical man-
ner. For instance, LMICs should avoid the unconditional 
acceptance of measures adopted in high-income countries 
that would result inappropriate in resource limited settings 
[52–54].
Overall, the number and significance of the ethical prob-
lems that emerged, which makes us understand how eth-
ics should be increasingly involved in guiding political and 
scientific legal reasoning, lead us to disagree with Stoeklé 
and Hervé [55], who, by separating political discussions, 
scientific knowledge and ethics writes: "now really isn’t the 
time for ethical reflections" and "ethics is only really useful 
if you have the time, and right now, time is exactly what we 
do not have."
5  Conclusions
This paper presented a systematic overview of scientific 
papers investigating ethical issues during the first wave 
of this pandemic. The papers highlighted some recurrent 
themes, namely the allocation of scarce resources, info-
demic, HCWs’ duty to treat versus personal protection, pri-
vacy, and the safeguard of minorities.
Reviewing such themes, a year after the outbreak of 
COVID-19, highlights several facts.
The infodemic has been as devastating as the virus. While 
it could have been acceptable in the first months of this 
pandemic, it is somehow surprising that after three waves 
of COVID-19, there is still confusion around trustworthy 
sources and reliable guidance. A year after, there is still mis-
information spread through digital social networks, although 
the object of the discussion has changed, focusing now on 
vaccination safety and scarcity, rather than MDs and PPE. 
The same doubts raised by Larson [15], Limaye et al. [13] 
and Bastani and Bahrami [16] in March 2020 on the inten-
tional repression of information perpetuated by governments 
for calming anxious publics during the first wave, have been 
recently repeated in regard to the surge of COVID-19 that 
affected India since March 2021.
After more than 12 months from the first wave, the ethical 
concerns on the stigma and discrimination against particular 
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populations is still relevant in many ways. For instance, sev-
eral authors hypothesize a causal link between COVID-19 
and the surge of violent acts towards Asians living in the 
USA [56, 57]. On the global scale, this discrimination will 
certainly not be mitigated by the delay in vaccinating popu-
lations in LMICs.
Moreover, the ethical concerns arising from balancing the 
need for track and trace with the risks for privacy, seem to be 
still unresolved. After a year and half into the pandemic, the 
same scepticism has crossed many COVID-19 waves result-
ing in several Apps being abandoned for more traditional 
phone-based methods. Similarly, the envisioned “real-time” 
monitoring based on randomized laboratory tests is still far 
from being possible and could still lead to incorrect political 
decisions heavily influencing the future of a country. One 
year on, in fact, although this risk has lowered, globally, it 
still is critical for some LMICs, where several challenges 
hinder COVID-19 testing [58].
Concerns on immunity certifications and pass, are yet far 
from being resolved, although the attention has now shifted 
towards the vaccines.
Concerning HCWs, the memory of recognising their 
efforts by cheering and clapping from the windows is far.
The scarcity of PPE and MDs seems to be overcome now, 
in many high-income countries, also thanks to the massive 
effort of United Nation agencies lead by the World Health 
Organization. Yet, the problem is far from being solved 
without structural interventions, as demonstrated by the 
surge in cases in India.
As regards the ethical issues on the appropriateness of 
economical evaluations and the transparency of political 
decisions, raised by authors during the first months of this 
pandemic, there is a need for more time before one can make 
unbiased reflections.
Inclusiveness seems to be one of the forgotten princi-
ples during this pandemic. While this issue was raised from 
the very start, the question remains open for several groups 
of populations, which have been not prioritised during the 
first wave, such as children, poor, unstable workers, chronic 
patients, and single parents.
Overall, this review identified a number of papers refer-
ring to ethics in their title, which in the end presented lit-
tle or no contribution to the ongoing discussion on ethical 
issues arising from COVID-19. While the attention of many 
scholars to this important topic is remarkable, we conclude 
this review with the doubt that ethics is still considered as a 
tick-box exercise by many, when not a “humanitarian embel-
lishment” of their technical work.
Conversely, ethics should be deeply interwoven with sci-
ence, theoretically and methodologically. Besides, helping the 
evaluation of the arising issues, ethics could help scientists 
ponder on the risk–benefit balance of their publications, and 
also on the final purpose of their work, i.e., the progress of 
humanity. The unprecedented number of retracted papers sug-
gests that during this pandemic the race to participate to the 
infodemic overcame the sense of responsibility, which should 
have imposed, in many cases, a responsible silence [59].
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